Literature DB >> 15086325

Identification of three F5 gene mutations associated with inherited coagulation factor V deficiency in two Chinese pedigrees.

Q-H Fu1, R-F Zhou, L-G Liu, W-B Wang, W-M Wu, Q-L Ding, Y-Q Hu, X-F Wang, Z-Y Wang, H-L Wang.   

Abstract

To investigate the molecular defects in two Chinese pedigrees with inherited factor V (FV) deficiency. A 37-year-old male (proband 1) and an 18-month-old boy (proband 2) were diagnosed as inherited coagulation FV deficiency by severely reduced plasma levels of FV activity and antigen. All 25 exons and their flanking sequence of F5 gene were amplified by polymerase chain reaction (PCR) for both probands and the PCR products were directly sequenced. Total RNA was extracted from the peripheral lymphocytes of proband 1 for detecting the changes at mRNA level. The homozygous deletion IVS8 -2A>G was identified in the F5 gene of proband 1 and complementary DNA (cDNA) analysis revealed the abolishment of the canonical splicing site by the mutation and the activation of the cryptic acceptor site 24 bp upstream instead. The insertion introduced eight additional amino acids (AA) into the FV protein. Two heterozygous mutations of F5 gene were discovered in proband 2. The 2238-9del AG in exon 13 introduced a premature termination code at 689 AA and the substitution of G6410 by T in exon 23 lead to the missense mutation Gly2079Val. Three F5 gene mutations, IVS8 -2A>G, 2238-9del AG and G6410T, have been identified in two Chinese pedigree with congenital FV deficiency, respectively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086325     DOI: 10.1111/j.1365-2516.2004.00896.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  1 in total

1.  Genome-wide prediction of cancer driver genes based on SNP and cancer SNV data.

Authors:  Quanze He; Quanyuan He; Xiaohui Liu; Youheng Wei; Suqin Shen; Xiaohui Hu; Qiao Li; Xiangwen Peng; Lin Wang; Long Yu
Journal:  Am J Cancer Res       Date:  2014-07-16       Impact factor: 6.166

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.